TMDX Q3 2023 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$66M+158.7% YoY

Gross Profit

$41M61.2% margin

Operating Income

-$28M-42.7% margin

Net Income

-$25M-38.3% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

+26.6%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$115M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$689M

Total Liabilities

$563M

Stockholders' Equity

$126M

Cash & Equivalents

$427M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$26M	+158.7%
Gross Profit	$41M	$18M	+124.5%
Operating Income	-$28M	-$6M	-411.1%
Net Income	-$25M	-$7M	-242.3%

Revenue Segments

Service

$15M57%

Product

$11M43%